Cannabidivarin (CBDV) Versus Placebo in Children with Autism Spectrum Disorder (ASD)

Abstract

The CDC currently estimates 1 in 59 children have Autism Spectrum Disorder (ASD). Children with ASD have problems with social communication, irritability, repetitive behaviors, impulsivity, temper tantrums, and a high caregiver burden. The only medications approved by the FDA for symptoms of ASD are aripiprazole and risperidone. Both of these are used to reduce irritability but have short-term and long-term side effects.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Aug 01, 2018
Accession Number
AD1064689

Entities

People

  • Eric Hollander

Tags

DTIC Thesaurus Topics

  • Anticonvulsants
  • Autism
  • Biomedical Research
  • Blood
  • Brain
  • Brain Injuries
  • Cells
  • Drug Abuse
  • Epilepsy
  • Health Services
  • Institutional Review Board
  • Intellectual Disability
  • Materials
  • Medical Personnel
  • Neurodevelopmental Disorders
  • New York
  • Pharmacies
  • Psychiatry
  • Seizures
  • Therapy
  • United States

Fields of Study

  • Medicine

Readers

  • Child and Adolescent Substance Abuse Science in Autism Spectrum Disorders.